Research Article

Related GMR Articles

Diabetic nephropathy; NF-κB; Rituximab; RKIP

This study aimed to investigate the expression levels of the Raf kinase inhibitor protein (RKIP) and NF-κB in renal tissues of diabetic nephropathy (DN) rats, and to determine the underlying molecular targets of rituximab (RTX), with the goal of developing new clinical treatment selection for DN. Sprague-Dawley rats were randomly divided into a normal group (N), a DN group (M), and an ... more

L. Li; Y.W. Zhao; J.S. Zeng; F. Fan; X. Wang; Y. Zhou; Z. Zhu
Beraprost sodium; Diabetic nephropathy; Inflammatory factors; Renal function

Beraprost sodium (BPS) is a prostaglandin analogue. We investigated its effects on rats with diabetic nephropathy. There were 20 rats each in the normal control group (NC), the diabetic nephropathy group (DN), and the BPS treatment group. The rats in DN and BPS groups were given a high-fat diet combined with low-dose streptozotocin intraperitoneal injections. The rats in the BPS group ... more

J. Guan; L. Long; Y.Q. Chen; Y. Yin; L. Li; C.X. Zhang; L. Deng; L.H. Tian
Diabetic nephropathy; Fibronectin; Human mesangial cells; Monocyte chemoattractant protein-1; Mycophenolate mofetil

The effects of high glucose on the expression of monocyte chemoattractant protein-1 (MCP-1) and the main component of the extracellular matrix, fibronectin (FN), were explored in human mesangial cells (HMCs), along with the intervention effects of mycophenolate mofetil (MMF) on these indicators. Cultured HMCs were divided into five groups: 1) normal control group (5 mM glucose); 2) high ... more

F.Q. Chen; Q.Y. Wang; G.Z. Wei; X.Y. Ma; D.W. Ma; W.W. Deng; W.B. Sun
Albuminuria; Astragaloside IV; Diabetic nephropathy; Potocyte

The aims of this study were to explore the effects of Astragaloside IV on diabetic nephropathy (DN) rats. A total of 38 male Sprague-Dawley (SD) rats were divided into three groups: 10 in the normal (control) group, 14 in the DN model group, and 14 in the AS-IV group. Treatment began one week after the streptozotocin DN model was successfully established. Blood glucose and urine micro- ... more

W.S. Lu; S. Li; W.W. Guo; L.L. Chen; Y.S. Li
Diabetic nephropathy; INSR; mTOR; Polymorphisms; Type 2 diabetes mellitus

We explored the associations of INSR and mTOR, 2 key genes in the insulin signaling pathway, and the susceptibility to type 2 diabetes mellitus and diabetic nephropathy. Three single-nucleotide polymorphisms (SNPs) (rs1799817, rs1051690, and rs2059806) in INSR and 3 SNPs (rs7211818, rs7212142, and rs9674559) in mTOR were genotyped using the Sequenom ... more

A.N. Zhu; X.X. Yang; M.Y. Sun; Z.X. Zhang; M. Li
Diabetic nephropathy; Gene polymorphism; Hypoxia-inducible factor-1α

We examined the correlation between gene polymorphisms in hypoxia-inducible factor-1α (HIF-1α) Pro582Ser and type 2 diabetic nephropathy (DN). A total of 244 subjects with type 2 diabetes were recruited. The 1285-bp locus polymorphism of HIF-1α exon was detected using polymerase chain reaction-restriction fragment length polymorphism. C/T single nucleotide polymorphisms were detected at ... more

Y.X. Bi; L. Yu; G.X. Jin